| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 07/27/1995 | CA2181488A1 N-phenyltetrahydrophthalamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient |
| 07/27/1995 | CA2180448A1 Monoazo dyes containing a fluorosulphonyl group and use thereof |
| 07/26/1995 | EP0664126A1 Inhibition of thrombin |
| 07/26/1995 | EP0664125A1 Inhibition of myeloperoxidase activity |
| 07/26/1995 | EP0664124A1 Treatment of atrophy of the skin and vagina |
| 07/26/1995 | EP0664123A1 Inhibition of autoimmune diseases |
| 07/26/1995 | EP0664122A1 Inhibition of imperfect tissue repair |
| 07/26/1995 | EP0664121A1 Inhibition of ldl oxidation and atherosclerosis |
| 07/26/1995 | EP0664117A1 Liposome solutions |
| 07/26/1995 | CA2140701A1 Liposome solutions |
| 07/25/1995 | US5436354 Enzyme inhibitors to inhibit squalene epoxidase and with antieumycetes |
| 07/25/1995 | US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor |
| 07/25/1995 | US5436267 N-phenylcarbamate compound, process for preparing the sasme and biocidal composition for control of harmful organisms |
| 07/25/1995 | US5436246 Serotonin receptor agents |
| 07/25/1995 | US5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation |
| 07/25/1995 | CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment |
| 07/25/1995 | CA1336429C Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient |
| 07/21/1995 | CA2140492A1 Substituted polyoxyalkylene compounds |
| 07/20/1995 | WO1995019357A1 Thiophene oxime derivative |
| 07/19/1995 | EP0663209A2 Medicament for inhibiting the effects of amyloidogenic proteins |
| 07/19/1995 | CN1105362A Methods for lowering serum cholesterol |
| 07/19/1995 | CN1105361A Methods for exhibiting angiogenisis and angiogenic diseases |
| 07/19/1995 | CN1105359A Methods for inhibiting smooth muscle cell proliferation and restinosis |
| 07/19/1995 | CN1105354A Novel alkamine derivative and slat of same |
| 07/18/1995 | US5434180 Skin disorders; retinoid activity; rheumatoid psoriasis; |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434172 Sulfonamide derivatives |
| 07/18/1995 | US5434166 Methods of inhibiting demyelinating and desmyelinating diseases |
| 07/18/1995 | US5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 07/13/1995 | WO1995018972A1 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 07/13/1995 | WO1995018799A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | WO1995018789A1 Pesticides |
| 07/13/1995 | WO1995018787A1 Selective asymmetric hydrogenation of dehydroamino acid derivatives using rhodium and iridium diphosphinite carbohydrate catalyst compositions |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995018607A1 Pharmaceutical compositions |
| 07/13/1995 | CA2180651A1 Phenyl heterocycles as cox-2 inhibitors |
| 07/13/1995 | CA2180526A1 Method of identifying chemical compounds having selected properties for a particular application |
| 07/13/1995 | CA2180446A1 Pharmaceutical compositions |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2178720A1 Selective asymmetric hydrogenation of dehydroamino acid derivatives using rhodium and iridium diphosphinite carbohydrate catalyst compositions |
| 07/12/1995 | EP0662475A2 Method for the preparation of 2-perfluoroalkyl-3-oxazolin-5-one |
| 07/12/1995 | EP0662472A1 Hydrazone derivates as pesticides |
| 07/12/1995 | EP0662325A2 Inhibition of ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 07/12/1995 | CN1104889A Cessation of tobacco use |
| 07/11/1995 | US5432197 Fungicidal propenoic acid derivatives |
| 07/11/1995 | US5432190 Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases |
| 07/06/1995 | WO1995018121A1 Novel benzylamine derivative |
| 07/06/1995 | WO1995018111A1 Compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
| 07/06/1995 | WO1995018102A1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | CA2139465A1 Hydrazone derivatives |
| 07/05/1995 | EP0661292A1 Orally active renin inhibitors |
| 07/05/1995 | EP0661260A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use |
| 07/05/1995 | EP0661258A1 Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses |
| 07/05/1995 | EP0660832A1 Serotonin receptor agents |
| 07/05/1995 | EP0660711A1 Novel use of inhibitors of phosphodiestersase iv |
| 07/04/1995 | US5430162 7-(substituted)-8-(substituted)-9-substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/04/1995 | US5430155 1,4-diamine-2,3-dihydroxy butanes |
| 07/04/1995 | US5430006 Herbicidal substituted thienylsulphonylureas |
| 07/04/1995 | CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives |
| 07/01/1995 | CA2139190A1 Method for the preparation of 2-perfluoroalkyl-3-oxazolin-5-one |
| 06/29/1995 | WO1995017382A1 Non-peptide tachykinin receptor antagonists |
| 06/29/1995 | WO1995017376A1 Aryl acetic acid derivatives |
| 06/29/1995 | WO1995017095A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
| 06/29/1995 | DE4446836A1 Alkyl-cyclohexyl-phenyl ester(s) of hetero-aromatic carboxylic acids |
| 06/29/1995 | CA2176130A1 Non-peptide tachykinin receptor antagonists |
| 06/29/1995 | CA2176127A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
| 06/28/1995 | EP0659737A2 Catecholamine surrogates useful as B3 agonists |
| 06/28/1995 | EP0659728A1 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same |
| 06/28/1995 | EP0659429A1 Raloncifene for inhibiting fertility in women |
| 06/28/1995 | EP0659428A1 2-Phenyl-3-azoylbenzothiophenes for treating obsessive-compulsive and consumptive disorders |
| 06/28/1995 | EP0659427A1 2-Phenyl-3-azoylbenzothiophenes for increasing thombomodulin expression |
| 06/28/1995 | EP0659426A1 2-Phenyl-3-azoylbenzothiophenes for treating pulmonary hypertensive diseases |
| 06/28/1995 | EP0659425A1 2-Phenyl-3-azoylbenzothiophenes for increasing macrophage function |
| 06/28/1995 | EP0659424A1 2-Phenyl-3-azoylbenzothiophenes for treating male infertility |
| 06/28/1995 | EP0659423A1 2-Phenyl-3-azoylbenzothiophenes for inhibiting weight gain or inducing weight loss |
| 06/28/1995 | EP0659422A1 2-Phenyl-3-azoylbenzothiophenes for treating Turner's syndrome |
| 06/28/1995 | EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms |
| 06/28/1995 | EP0659420A1 2-Phenyl-3-azoylbenzothiophenes for treating sexual precocity |
| 06/28/1995 | EP0659419A1 2-Phenyl-3-azoylthiophenes for inhibiting breast disorders |
| 06/28/1995 | EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease |
| 06/28/1995 | EP0659417A2 Inhibition of dysfunctional uterine bleeding |
| 06/28/1995 | EP0659416A2 Inhibition of seborrhea and acne |
| 06/28/1995 | EP0659415A2 Inhibition of vasomotor symptoms and treatment of psychological disturbances surrounding post-menopausal syndrome |
| 06/28/1995 | EP0659414A2 Inhibition of hirsutism and alopecia in women |
| 06/28/1995 | EP0659413A2 Inhibition of CNS problems in post-menopausal women |
| 06/28/1995 | EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 06/28/1995 | EP0659411A2 Method for increasing libido in post-menopausal women |
| 06/28/1995 | EP0401302B1 Method of preparing a metal-radionuclide-labelled protein |
| 06/28/1995 | CN1104214A Novel 2-thiosubstituted carbapenems |
| 06/28/1995 | CN1029123C Process for preparation of insecticidal cyclopropyl-substituted di(aryl) compounds |
| 06/27/1995 | US5428174 Preparation of α,β-unsaturated ketones |
| 06/27/1995 | US5428058 Phospholipase A2 inhibitors |
| 06/27/1995 | US5428052 Classifiable as retinoids; skin disorders, corneopathy |
| 06/27/1995 | US5428044 Anti-inflammatory 4-aminophenyl derivatives |
| 06/27/1995 | US5428037 Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
| 06/27/1995 | CA1336099C Urea based lipoxygenase compounds |
| 06/22/1995 | CA2138513A1 Methods of inhibiting myeloperoxidase activity |
| 06/22/1995 | CA2138511A1 Methods of inhibiting atrophy of the skin and vagina |
| 06/22/1995 | CA2138510A1 Methods of inhibiting dysfunctional uterine bleeding |